Biologic aspects of thrombopoietins and the development of therapeutic agents.
about
The Use of Thrombopoietin Receptor Agonists for Correction of Thrombocytopenia prior to Elective Procedures in Chronic Liver Diseases: Review of Current EvidenceSuspects in the tale of lupus-associated thrombocytopenia.Mathematical model of platelet turnover in thrombocytopenic and nonthrombocytopenic preterm neonatesManagement of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies.
P2860
Biologic aspects of thrombopoietins and the development of therapeutic agents.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Biologic aspects of thrombopoietins and the development of therapeutic agents.
@ast
Biologic aspects of thrombopoietins and the development of therapeutic agents.
@en
type
label
Biologic aspects of thrombopoietins and the development of therapeutic agents.
@ast
Biologic aspects of thrombopoietins and the development of therapeutic agents.
@en
prefLabel
Biologic aspects of thrombopoietins and the development of therapeutic agents.
@ast
Biologic aspects of thrombopoietins and the development of therapeutic agents.
@en
P1476
Biologic aspects of thrombopoietins and the development of therapeutic agents.
@en
P2093
Lawrence A Solberg
P304
P577
2005-11-01T00:00:00Z